The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 77.
252. lappuse
... utility as a pharmaceutical . Is the first inventor entitled to a claim to the novel homologue when he points out this new utility to the examiner ? Mr. Frost : That is the In re Nelson case . Fairly close . What hap- pened in the ...
... utility as a pharmaceutical . Is the first inventor entitled to a claim to the novel homologue when he points out this new utility to the examiner ? Mr. Frost : That is the In re Nelson case . Fairly close . What hap- pened in the ...
262. lappuse
... UTILITY The patent laws provide that to be patentable an invention must have utility . Further , the utility of the invention must be made clear by the patent application . Utility need be only slight so long as the invention is capable ...
... UTILITY The patent laws provide that to be patentable an invention must have utility . Further , the utility of the invention must be made clear by the patent application . Utility need be only slight so long as the invention is capable ...
300. lappuse
... utility be conclusively predict- able from the work which the inventor has done.58 It also is not necessary that the disclosure of utility indicate that the requirements of a reduction to practice have been met ; that is , that the ...
... utility be conclusively predict- able from the work which the inventor has done.58 It also is not necessary that the disclosure of utility indicate that the requirements of a reduction to practice have been met ; that is , that the ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention